Abstrakt

Przypisy

• 1. Arsic N., Bendris N., Peter M., Begon-Pescia C., RebouissouC., Gadéa G., Bouquier N., Bibeau F., Lemmers B., Blanchard J.M.:A novel function for Cyclin A2: control of cell invasion via RhoAsignaling. J. Cell Biol., 2012; 196: 147-162
  Google Scholar
• 2. Beamish H., de Boer L., Giles N., Stevens F., Oakes V., GabrielliB.: Cyclin A/cdk2 regulates adenomatous polyposis coli-dependentmitotic spindle anchoring. J. Biol. Chem., 2009; 284: 29015-29023
  Google Scholar
• 3. Cheng J., Wei H.L., Chen J., Xie B.: Antitumor effect of arsenictrioxide in human K562 and K562/ADM cells by autophagy. Toxicol.Mech. Methods, 2012; 22: 512-519
  Google Scholar
• 4. Chibazakura T., Kamachi K., Ohara M., Tane S., Yoshikawa H.,Roberts J.M.: Cyclin A promotes S-phase entry via interactionwith the replication licensing factor Mcm7. Mol. Cell. Biol., 2011;31: 248-255
  Google Scholar
• 5. Ehrhardt H., Schrembs D., Moritz C., Wachter F., Haldar S.,Graubner U., Nathrath M., Jeremias I.: Optimized anti-tumor effectsof anthracyclines plus Vinca alkaloids using a novel, mechanism-basedapplication schedule. Blood, 2011; 118: 6123-6131
  Google Scholar
• 6. Elmore S.: Apoptosis: a review of programmed cell death. Toxicol.Pathol., 2007; 35: 495-516
  Google Scholar
• 7. Foster K.A., Oster C.G., Mayer M.M., Avery M.L., Audus K.L.:Characterization of the A549 cell line as a type II pulmonary epithelialcell model for drug metabolism. Exp. Cell Res., 1998; 243:359-366
  Google Scholar
• 8. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., HuntT.: Anaphase-promoting complex/cyclosome-dependent proteolysisof human cyclin A starts at the beginning of mitosis andis not subject to the spindle assembly checkpoint. J. Cell Biol.,2001; 153: 137-148
  Google Scholar
• 9. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H.,Dosik H., Parks W.P.: In vitro cultivation of human tumors: establishmentof cell lines derived from a series of solid tumors. J. Natl.Cancer Inst., 1973; 51: 1417-1423
  Google Scholar
• 10. Gong D., Ferrell J.E.Jr.: The roles of cyclin A2, B1, and B2 inearly and late mitotic events. Mol. Biol. Cell, 2010; 21: 3149-3161
  Google Scholar
• 11. Gong D., Pomerening J.R., Myers J.W., Gustavsson C., Jones J.T.,Hahn A.T., Meyer T., Ferrell J.E.Jr.: Cyclin A2 regulates nuclearenvelopebreakdown and the nuclear accumulation of cyclin B1.Curr. Biol., 2007; 17: 85-91
  Google Scholar
• 12. Grzanka A., Żuryń A., Styczyński J., Grzanka A.A., WiśniewskaH.: The effect of doxorubicin on the expression of cyclin A in K-562leukemia cell line. Neoplasma, 2005; 52: 489-493
  Google Scholar
• 13. Han Y.H., Kim S.Z., Kim S.H., Park W.H.: Induction of apoptosisin arsenic trioxide-treated lung cancer A549 cells by buthioninesulfoximine. Mol. Cells, 2008; 26: 158-164
  Google Scholar
• 14. Huang Y., Sramkoski R.M., Jacobberger J.W.: The kinetics of G2and M transitions regulated by B cyclins. PLoS One, 2013; 8: e80861
  Google Scholar
• 15. Hukkanen J., Lassila A., Päivärinta K., Valanne S., Sarpo S.,Hakkola J. Pelkonen O., Raunio H.: Induction and regulation ofxenobiotic-metabolizing cytochrome P450s in the human A549lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol., 2000;22: 360-366
  Google Scholar
• 16. Jackman M., Kubota Y., den Elzen N., Hagting A., Pines J.: CyclinA- and cyclin E-Cdk complexes shuttle between the nucleusand the cytoplasm. Mol. Biol. Cell, 2002; 13: 1030-1045
  Google Scholar
• 17. Kabeche L., Compton D.A.: Cyclin A regulates kinetochoremicrotubulesto promote faithful chromosome segregation. Nature,2013; 502: 110-113
  Google Scholar
• 18. Kim J., Lee J.J., Kim J., Gardner D., Beachy P.A.: Arsenic antagonizesthe Hedgehog pathway by preventing ciliary accumulationand reducing stability of the Gli2 transcriptional effector. Proc.Natl. Acad. Sci. USA, 2010; 107: 13432-13437
  Google Scholar
• 19. Li L., Wang J., Ye R.D., Shi G., Jin H., Tang X., Yi J.: PML/RARαfusion protein mediates the unique sensitivity to arsenic cytotoxicityin acute promyelocytic leukemia cells: mechanisms involvethe impairment of cAMP signaling and the aberrant regulation ofNADPH oxidase. J. Cell Physiol., 2008; 217: 486-493
  Google Scholar
• 20. Li X., Ding X., Adrian T.E.: Arsenic trioxide induces apoptosisin pancreatic cancer cells via changes in cell cycle, caspase activation,and GADD expression. Pancreas, 2003; 27: 174-179
  Google Scholar
• 21. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G.:A continuous tumor-cell line from a human lung carcinoma withproperties of type II alveolar epithelial cells. Int. J. Cancer, 1976;17: 62-70
  Google Scholar
• 22. Livak K.J., Schmittgen T.D.: Analysis of relative gene expressiondata using real-time quantitative PCR and the 2-ΔΔCT method.Methods, 2001; 25: 402-408
  Google Scholar
• 23. Pascreau G., Eckerdt F., Churchill M.E., Maller J.L.: Discoveryof a distinct domain in cyclin A sufficient for centrosomal localizationindependently of Cdk binding. Proc. Natl. Acad. Sci. USA,2010; 107: 2932-2937
  Google Scholar
• 24. Qi Y., Tu Y., Yang D., Chen Q., Xiao J., Chen Y., Fu J., Xiao X.,Zhou Z.: Cyclin A but not cyclin D1 is essential for c-myc-modulatedcell-cycle progression. J. Cell. Physiol., 2007; 210: 63-71
  Google Scholar
• 25. Qu G.P., Xiu Q.Y., Li B., Liu Y.A., Zhang L.Z.: Arsenic trioxideinhibits the growth of human lung cancer cell lines via cell cyclearrest and induction of apoptosis at both normoxia and hypoxia.Toxicol. Ind. Health, 2009; 25: 505-515
  Google Scholar
• 26. Tsang W.Y., Wang L., Chen Z., Sánchez I., Dynlacht B.D.: SCAPER,a novel cyclin A-interacting protein that regulates cell cycleprogression. J. Cell Biol., 2007; 178: 621-633
  Google Scholar
• 27. Walker A.M., Stevens J.J., Ndebele K., Tchounwou P.B.: Arsenictrioxide modulates DNA synthesis and apoptosis in lung carcinomacells. Int. J. Environ. Res. Public Health, 2010; 7: 1996-2007
  Google Scholar
• 28. Wu X., Shi J., Wu Y., Tao Y., Hou J., Meng X., Hu X., Han Y., Jiang W., Tang S., Zangari M., Tricot G., Zhan F.: Arsenic trioxidemediatedgrowth inhibition of myeloma cells is associated withan extrinsic or intrinsic signaling pathway through activation ofTRAIL or TRAIL receptor 2. Cancer Biol. Ther., 2010; 10: 1201-1214
  Google Scholar
• 29. Yano Y., Satoh H., Fukumoto K., Kumadaki I., Ichikawa T., YamadaK., Hagiwara K., Yano T.: Induction of cytotoxicity in humanlung adenocarcinoma cells by 6-O-carboxypropyl-α-tocotrienol,a redox-silent derivative of α-tocotrienol. Int. J. Cancer, 2005;115: 839-846
  Google Scholar
• 30. Żuryń A., Grzanka A., Stępień A., Grzanka D., Dębski R.,Smoliński D.: Expression of cyclin A in human leukemia cell lineHL-60 following treatment with doxorubicin and etoposide: thepotential involvement of cyclin A in apoptosis. Oncol. Rep., 2007;17: 1013-1019
  Google Scholar

Pełna treść artykułu